year of use) were included. 63 used GSM and 62 CDMA phones. Another 58 subjects acted as controls who had never used any mobile phone. The subjects underwent battery of investigations including pure tone audiometry (250Hz-12 KHz), tympanometry, distortion product otoacoustic emissions, auditory brain responses and middle latency responses. The changes in various parameters were studied in mobile and non mobile ears of GSM and CDMA subjects and corresponding ears of controls to ascertain the effects of electromagnetic exposure. RESULTS: GSM and CDMA users had a significantly higher risk of having absent OAE as compared to controls (pϽ0.05). They were found to have higher speech frequency thresholds, lower MLR wave Na and Pa amplitude. More than 3 years of mobile phone usage and more than one hour of cumulative daily usage emerged as risk factors. (pϽ0.05). The damage was bilateral and quantum being same for both GSM and CDMA users. CONCLUSION: Long term and intensive GSM and CDMA mobile phone use may cause damage to cochlea as well as auditory cortex.
Bacterial Infection in Otitis Media with Effusion
Shehla Imtiaz-Umer, MSc (presenter); Mat Daniel, MBChB, FRCSEd; Neil Fergie, MD, FRCS; John Birchall, MD, FRCS; Roger Bayston, MMedSci, PhD, FRCPath OBJECTIVE: OME is thought to be a result of bacterial infection, but fewer than half of effusion samples are positive using standard culture techniques. On the other hand, Polymerase Chain Reaction detects bacterial DNA in about 80%. This may be explained by recent suggestions that bacteria existing as biofilms cause OME, because such bacteria are difficult to culture. We adopted an alternative approach to demonstrating bacteria in OME, using 1) a bacterial viability stain and 2) confocal laser scanning microscopy (CLSM). Staining allows detection of live bacteria without requiring them to grow on culture, whilst CLSM demonstrates threedimensional structure of bacterial communities typical of biofilms. METHOD: Following disinfection of ear canals, effusion samples were collected at grommet insertion. Extended culture techniques were performed with intention of capturing all possible organisms. Samples were analyzed by CLSM after staining with a bacterial viability kit. RESULTS: 62 samples from 41 patients were analyzed. Of 62 effusions, 28 (45.2%) were culture-positive, but 51 (82.3%) were positive at LCSM. Combining the two techniques, live bacteria were demonstrated in 57 (91.8%) samples. On LCSM, bacteria exhibited biofilm morphology in 25 effusions and planktonic in 26; the proportion of samples exhibiting biofilm morphology was similar in the culture-positive and culturenegative groups (50.0% and 48.3%, respectively). CONCLUSION: Combining culture and LCSM demonstrates live bacteria in majority of effusions, confirming the important role of bacteria in aetiopathogenesis of OME. Biofilms are important as they are themselves pathogenic, may also act as a reservoir of planktonic bacteria, and may represent a future therapeutic target.
BAHA and BMI: Does Obesity Influence Complication Rates?
Constance Zhou, MD (presenter); Joe Kutz, MD; Timothy Molony, MD; Kevin Motamedi OBJECTIVE: 1) Understand the association between obesity and risk for soft tissue BAHA complications. 2) Be able to identify patients at increased risk for soft tissue BAHA complications. METHOD: Study design: Retrospective case review. Setting: Two tertiary referral centers. Patients: Adult patients with at least six months follow-up after BAHA surgery. These patients were grouped according to body-mass index (BMI) scores. Intervention(s): BAHA implantation, BAHA site revision. Main outcome measure: Occurrence of soft tissue overgrowth requiring operative revision. Statistical analysis was performed using logistic regression. RESULTS: Seventy-one patients met inclusion criteria, onethird of whom where clinically obese. Follow-up time averaged 2.3 years. The incidence of soft tissue overgrowth requiring revision surgery was 6.5% in the non-obese cohort and 28.6% in the obese group (pϽ0.05). CONCLUSION: Obesity confers an increased risk for soft tissue overgrowth complicating BAHA use.
Balloon Catheter Dilation of Eustachian Tube: Pilot Study
Vivian Yu, MS (presenter); Sashikanth Jonnalagadda, MD; Peter Catalano, MD OBJECTIVE: At the conclusion of this presentation, participants should be able to describe the indications, technique, and outcomes of endoscopic Eustachian tube balloon dilation. METHOD: Eustachian tube balloon dilation procedures performed at a tertiary care medical center from January to September 2009 were prospectively reviewed with respect to clinical outcomes and complications. The procedure was performed on 30 patients. This technique involves endoscopic placement of a 5mm sinus balloon catheter into the proximal Eustachian tube, and inflating the balloon to dilate the cartilaginous Eustachian tube. Cases were reviewed with respect to indications, outcomes, and complications. RESULTS: 53 Eustachian tubes of 30 patients were dilated and analyzed. Of these 53 ears, 39% were unilateral procedures and 25% were dilated under local anesthetic in the office. 75% were performed in the OR during some other procedure. Indications included persistent middle ear effusions (44%), aural fullness (36%), and other middle ear diseases in the rest. Sixty % of patients felt their aural fullness had resolved after one treatment. No patients reported any pain, hearing loss, or infection. CONCLUSION: Treatment of Eustachian tube dysfunction has traditionally focused on otologic approaches. Endoscopic Eustachian tube balloon dilation is a novel approach to treating Eustachian tube dysfunction in select patients and offers potential benefits and a high safety profile. This minimally invasive technique holds much promise and merits further investigations and refinements.
Balloon Dilation of the Cartilaginous Eustachian Tube
Dennis Poe, MD (presenter); Juha Silvola, MD, PhD OBJECTIVE: 1) To translate techniques developed in a previous cadaver study of balloon dilation of the cartilaginous Eustachian tube (ET) into clinical treatment for refractory dilatory dysfunction. 2) To study the safety/efficacy of the technique in a pilot clinical trial. METHOD: Design: A prospective study was conducted at an academic center starting June 2009 on 12 consecutive adult patients with longstanding otitis media with effusion (OME) or tympanic membrane (TM) atelectasis, and who served as their historical controls. Subjects were unable to autoinsufflate their ET by Valsalva, swallow, or yawn and 11/12 had previous tympanostomies (ave 4.3). At the time of the procedure, 6/12 had a tube; 2/12 a TM perforation (6/8 continued to have mucoid otorrhea); 3/12 had tympanogram type B; and 1/12 type C. 4/12 had atelectasis. Intervention: Balloon dilation of the cartilaginous ET was performed with sinus dilation instruments via transnasal endoscopic approach under general anesthesia in a day surgery setting. Inflation was to a maximum of 12 atm for one minute. Outcome measures: presence of otorrhea, ability to autoinsufflate, tympanogram, atelectasis RESULTS: All cases successfully dilated. Mucoid otorrhea persisted in 1/8; 12/12 could autoinsufflate (pϽ0.001); tympanograms were A: 4/12, C: 1/12, or open: 7/12. All atelectases resolved. Procedures were well tolerated, without pain or complications related to dilation. CONCLUSION: Dilation of the cartilaginous ET was demonstrated to be an initially effective and safe procedure for the treatment of ET dilatory dysfunction. Larger controlled trials with long-term results are now needed and justified.
Bed Rest for Idiopathic Sudden Sensorineural Hearing Loss
Gilead Berger, MD (presenter); Tali Landau Zemer, MD; Michael Wolf, MD; Jona Kronenberg, MD OBJECTIVE: Assess the hearing benefit of bed rest in addition to oral prednisone treatment in patients with sudden sensorineural hearing loss (SSNHL). METHOD: Double centered, prospective, controlled study, conducted in the years 2006-2009. Subjects studied were adult patients with SSNHL. Both the study and control group were treated with oral prednisone 1mg/kg for one week with tapering down. The study group was admitted and instructed to keep strict bed rest. The control group was given no recommendation for bed rest. Complete recovery was defined as improvement in hearing threshold to normal range (average pure tone eudiometry (aPTA) Ն 25 dB or within 10 dB range of the unaffected ear). Partial recovery was defined as improvement in aPTA м 15 dB. No recovery was defined as improvement in aPTA Ͻ 15 dB. Improvement was assessed for low frequencies (500, 1000 and 2000 Hz) and high frequencies (4000 and 8000 Hz). RESULTS: Both the study and control group consisted of 34 patients. No significant difference was found in low frequencies improvement rate between the study and control group. High frequencies improvement rate significantly differ between the study and control group: complete, partial and no improvement rate were 57%, 23%, 20% and 18%, 50%, 32% respectively, (pϭ0.005). Logistic regression analysis indicated that admission aPTA on high frequencies, bed rest and age were independent variables predicting high frequencies improvement (pϭ0.0003, pϭ0.003, pϭ0.04, respectively). CONCLUSION: Our data support the policy of recommending bed rest in addition to oral prednisone treatment for patients with sudden sensorineural hearing loss.
Bone Conduction via Teeth for Unilateral Deafness, Validated
Michael Murray, MD (presenter); Gerald Popelka, PhD; Ross Miller, DDS, MS; Jennifer Tucker, AuD; Rebecca Dolan, AuD OBJECTIVE: 1) Describe a new, non-surgical bone conduction device (Sonitus SoundBite) that uses an ear level module with a microphone in the ear canal of the impaired ear and a removable oral appliance that applies a very wide bandwidth signal to a tooth surface. 2) Present results of a multi-center clinical study that measured the auditory performance, practical benefits and safety of this new device for SSD patients. METHOD: Subjects with acquired SSD (Nϭ28) wore the new device for a 30 day trial period. The primary outcome was a measure of ability to hear in noise using the Hearing In Noise Test (HINT) with the device compared to without it. The secondary outcome was a measure of changes in the auditory impact in daily life using the Abbreviated Profile of Hearing Aid Benefit (APHAB). RESULTS: The device provided a 2.5 dB advantage on the HINT (pϽ0.001) at the end of the 30-day trial period com-
